GLP-1 receptor agonists like Semaglutide and Tirzepatide have demonstrated significant cardiovascular Gains, like lowered risk of important adverse cardiovascular functions (MACE) like coronary heart attack and stroke44. • Kidney troubles: May well produce dehydration and worsen kidney functionality in patients with pre-present kidney conditions. In determining to employ a https://normanw100qgx9.mybuzzblog.com/profile